微博
加入微博一起分享新鲜事
登录
|
注册
140
Efficacy and Safety of Baricitinib for the Treatment of Hospitalized Adults with Severe or Critical COVID-19 (Bari-SolidAct): A Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Phase 3 Trial https://icostatistics.no/publication/troseid-efficacy-2022/
请登录并选择要私信的好友
300
Efficacy and Safety of Baricitinib for the Treatment of Hospitalized Adults with Severe or Critical COVID-19 (Bari-SolidAct): A Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Phase 3 Trial https://icostatistics.no/publication/troseid-efficacy-2022/
赞一下这个内容
公开
分享
获取分享按钮
正在发布微博，请稍候